You cannot select more than 25 topics Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
JobMarketPaper/Paper/sections/09_Conclusion.tex

44 lines
2.1 KiB
TeX

\documentclass[../Main.tex]{subfiles}
\graphicspath{{\subfix{Assets/img/}}}
\begin{document}
Identifying commercial impediments to successfully completing
clinical trials in otherwise capable pharmaceuticals will hopefully
lead to a more robust and competitive pharmaceutical market.
%FIXTAG: too much "hopefully"
Although the current state of this research is insufficient to draw robust
conclusions, these early results suggest that delaying the close of
enrollment period reduces the probability of termination of a trial.
%FIXTAG: OK for now but I think there might be a better way to handle this for now
% The successful completion of Phase III clinical trials is crucial for
% bringing new treatments to market.
%FIXTAG: needs to be earlier
The primary limitation that must be addressed before drawing a strong conclusion
is that of insufficient data.
%FIXTAG: This needs rewritten
This takes two forms.
%FIXTAG: needs better transition
The first is the small sample size.
To overcome this requires an improved data matching
approach and a revised data scraper.
%FIXTAG: active voice: this can be overcome by...
The second is creating a model of enrollment that can be used to address
the causal identification issue from the joint determination of
enrollment statuses and elapsed durations of trials.
%FIXTAG: sentence is too complicated
Despite these limitations, this work establishes a framework for analyzing
operational versus strategic factors in clinical trial completion.
%FIXTAG: analyzing replaced with "separating causal effects"
The approach developed here can be extended with additional data to
provide more definitive guidance on enrollment management strategies.
%FIXTAG: the approach here + additional data can provide
%FIXTAG: tie to next sentence better
Further research in this direction could help reduce operational
barriers to trial completion or estimating the impact policies may have through
operational channels.%FIXTAG: clauses don't match. first clause needs tightened.
Ultimately this work will hopefully support more efficient drug
development and increased market competition. %FIXTAG: wishy-washy and duplicative.
\end{document}